| Structure |
Chemical Name |
CAS |
MF |
![[2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1)](/CAS/20250703/GIF/2945838-77-5.gif) |
[2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1) |
2945838-77-5 |
C27H30FN7O.C2H4O2 |
![Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, 109-ester with human fibroblast growth factor 21 [109-[4-[1-[[2-(carboxyamino)ethoxy]imino]ethyl]-L-phenylalanine]] (ACI)](/) |
Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, 109-ester with human fibroblast growth factor 21 [109-[4-[1-[[2-(carboxyamino)ethoxy]imino]ethyl]-L-phenylalanine]] (ACI) |
2089039-22-3 |
|
 |
レナバスム |
137945-48-3 |
C25H36O4 |
|
|
Belapectin |
1980787-47-0 |
|
|
|
Pamrevlumab |
946415-13-0 |
|
 |
Nインテダニブ |
656247-17-5 |
C31H33N5O4 |
![3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)-](/CAS/20210305/GIF/2241808-52-4.gif) |
3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- |
2241808-52-4 |
C15H19Cl2N3O |
 |
2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)- |
2409963-83-1 |
C13H13FN2O2S |
![3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, hydrochloride (1:1), (2R,3S)-](/CAS/20211123/GIF/2891676-17-6.gif) |
3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, hydrochloride (1:1), (2R,3S)- |
2891676-17-6 |
C15H20Cl3N3O |
 |
Pirfenidone-d3 |
1093951-85-9 |
C12H11NO |
 |
2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, hydrochloride, hydrate (1:2:1), (2Z)- |
2414974-55-1 |
C13H16ClFN2O3S |
 |
ピルフェニドン |
53179-13-8 |
C12H11NO |
![2-[4-methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indane-2-carboxylic acid](/CAS/20180703/GIF/1195941-38-8.gif) |
2-[4-methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indane-2-carboxylic acid |
1195941-38-8 |
C27H27NO5 |